Linked Life Data

17869659

Source:http://linkedlifedata.com/resource/pubmed/id/17869659

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-9-17
pubmed:abstractText
In lung cancer, stage is an important prognostic factor for disease progression and survival. However, stage may be simply a surrogate for underlying tumor burden. Our purpose was to assess the prognostic value of tumor burden measured by 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0360-3016
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
69
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
328-33
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Metabolic tumor burden predicts for disease progression and death in lung cancer.
pubmed:affiliation
Department of Radiation Oncology, Stanford University, Stanford, CA 94305-5847, USA.
pubmed:publicationType
Journal Article